Regulations.gov document
Patient-Focused Drug Development: Methods to Identify What Is Important to Patients…
Other · FDA-2019-D-4247 · posted Oct 1, 2019
Key facts
| Document ID | FDA-2019-D-4247-0002 |
|---|---|
| Title | Patient-Focused Drug Development: Methods to Identify What Is Important to Patients Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; DRAFT GUIDANCE |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2019-D-4247 |
| Posted | Oct 1, 2019 |
| Comment period opens | Oct 1, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: